Sweethoven Biotech
Sweethoven Biotech develops natural fiber-based sugar alternatives that offer prebiotic and low-glycemic properties as a substitute for excessive sugar intake.
Classification
Profile
Not yet available.
Funding
Funding details not yet available.
Compliance
Natural fiber-based sugar alternatives combining taste, texture, and nutrition with prebiotic and low-glycemic properties.
Food & Beverage manufacturers - looking for clean-label, low-calorie sweeteners that meet regulatory sugar-reduction targets · Ingredient distributors - who supply specialty functional ingredients to the food industry · Health-focused brands - e-commerce snack producers, dairy alternatives, sports nutrition firms that market “no-added-sugar” claims
- Ingredient sales - bulk supply of the dietary fiber to manufacturers (future scaling)
Direct B2B outreach - email (info@sweethoven-biotech.com), university-linked networking events, industry incubators (EIT Food Seedbed) · Strategic partnerships - pilot production with food manufacturers via BMBF DATIpilot funding · Trade shows & conferences - ANUGA, EIT Food Venture Summits, NEXT BITE (2023-2024)
Alumni of the EIT Food Seedbed Incubator, providing early-stage support and networking opportunities at Germany's premier biotech events.
R&D & personnel - salaries for scientists, engineers, IP lawyers · Pilot-plant operations - consumables, bioreactor time, quality testing · Regulatory & compliance - dossier preparation, third-party testing
Proprietary natural fiber technology offering prebiotic and low-glycemic benefits as a non-synthetic sugar alternative.
Developing fiber-based sugar alternatives that integrate taste, texture, and nutrition without using blends or synthetic compounds.
Co-development & technical support - joint R&D with manufacturers to integrate the fiber into formulations · Licensing agreements - long-term, royalty-based relationships for ingredient use · Knowledge sharing - webinars, white-papers on health benefits, sustainability metrics
Competes with synthetic sugar substitutes by offering a natural fiber solution that provides prebiotic benefits and low-glycemic properties.
Excessive sugar intake and the need for sugar alternatives that maintain taste and texture while offering nutritional benefits.
- Accelerate scale-up through contract manufacturing - Partner with an established GMP-certified biotech CDMO to move from 50 kg pilot batc
- Target launch timeline - When does Sweethoven plan to move from pilot batches to commercial-scale supply?
Revenue is tightly coupled to Key Activities (production scale-up) and Key Resources (patents, biocatalyst strains)
- Strong academic foundation - Originating from University of Bonn’s IFMB and backed by the Transfer Center enaCom gives scientific credibi
Team details not yet available.
No investors recorded yet.